Syntheses and biological evaluation of 1-heteroaryl-2-aryl-1H-benzimidazole derivatives as c-Jun N-terminal kinase inhibitors with neuroprotective effects

Add time:08/29/2019    Source:sciencedirect.com

1-Heteroaryl-2-aryl-1H-benzimidazole derivatives were synthesized as inhibitors of c-Jun N-terminal kinases, JNK3. Their activities were evaluated through measurement of Kd using SPR, JNK3 kinase assay, and cell-viability of human neuroblastoma cells. Most tested compounds showed high affinity (10 μM–46 nM) to JNK3. Among them, compound 16f exhibited potent activities (Kd = 46 nM). Especially, 16f was also found to present a potent cell protective effect (IC50 = 1.09 μM) against toxicity induced by anisomycin, showing a possibility as protective therapeutics in neuronal cell apoptosis.

We also recommend Trading Suppliers and Manufacturers of Methanone, (2,4-dichlorophenyl)[1-(1H-imidazol-1-yl)cyclopropyl]- (cas 111262-22-7). Pls Click Website Link as below: cas 111262-22-7 suppliers

Prev:Insights into the Alkyl Peroxide Reduction Pathway of Xanthomonas campestris bacterioferritin comigratory protein (cas 136253-16-2) from the Trapped Intermediate–Ligand Complex Structures
Next:Crystal structure, spectroscopic investigations and quantum chemical calculation studies of (3aR,6S,7aR)-7a-bromo-6-methyl-2-[(4-methylphenyl)sulfonyl]-1,2,3,6,7,7a-hexahydro-3a,6-epoxyisoindole: A combined experimental and theoretical studies)